Abstract:Cisplatin is one of the most widely used chemotherapeutic agents for various solid tumors in the clinic due to its high efficacy and broad spectrum. The antineoplastic activity of cisplatin is mainly due to its ability to cross-link with DNA, thus blocking transcription and replication. Unfortunately, the clinical use of cisplatin is limited by its severe, dose-dependent toxic side effects. There are approximately 40 specific toxicities of cisplatin, among which nephrotoxicity is the most common one. Other common side effects include ototoxicity, neurotoxicity, gastrointestinal toxicity, hematological toxicity, cardiotoxicity, and hepatotoxicity. These side effects together reduce the life quality of patients and require lowering the dosage of the drug, even stopping administration, thus weakening the treatment effect. Few effective measures exist clinically against these side effects because the exact mechanisms of various side effects from cisplatin remain still unclear. Therefore, substantial effort has been made to explore the complicated biochemical processes involved in the toxicology of cisplatin, aiming to identify effective ways to reduce or eradicate its toxicity. This review summarizes and reviews the updated advances in the toxicological research of cisplatin. We anticipate to provide insights into the understanding of the mechanisms underlying the side effects of cisplatin and designing comprehensive therapeutic strategies involving cisplatin.

Advances in Research on the Effects of Traditional Chinese Medicines on Platinum Antitumor Drugs

Research progress in toxic effects of antitumor drugs based on drug transporter

Clinical Evaluation on Platinum Anticancer Drugs

Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy

Advances in Toxicological Research of the Anticancer Drug Cisplatin

Research progress of natural product-conjugated platinum and gold complexes as potential antitumor agents

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Advances in Research on Traditional Chinese Medicines with Anti-tumor Metastasis Activity and Their Clinical Application

Advances in Drug Delivery System for Platinum Agents Based Combination Therapy.

Adverse reactions, prevention and treatment of platinum compounds

Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention

Trends of Platinum and Metal-Arene Anticancer Drugs Based on Natural Products

Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives

Research Progress of Metal Anticancer Drugs

Review: Recent Advances and Future Development of Metal Complexes As Anticancer Agents

Recent Development in Platinum Complexes with Anticancer Activities and the Underlying Mechanisms

Platinum-based drugs for cancer therapy and anti-tumor strategies

Progress In Non-Classical Antitumor Platinum Drugs

Progress on the study of non-platinum metallic drugs in antitumor

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Pharmacogenomics for the Efficacy of Platinum-Based Chemotherapy: Old Drugs, New Integrated Perspective.